Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Evaluation of antibiotics consumption in therapeutic intensive care department

Show simple item record

dc.contributor.author Bernaz, Emilian
dc.date.accessioned 2019-06-24T23:28:54Z
dc.date.available 2019-06-24T23:28:54Z
dc.date.issued 2016
dc.identifier.citation BERNAZ, Emilian. Evaluation of antibiotics consumption in therapeutic intensive care department. In: Curierul Medical. 2016, vol. 59, no 2, pp. 5-10. ISSN 1875-0666.
dc.identifier.issn 1857-0666
dc.identifier.uri http://curierulmedical.org/wp-content/uploads/2016/09/Cm-2-0-2016-PDF-Integral-3.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/3003
dc.description.abstract Background: Monitoring of aggregate, ward-supply data and analysis of the anatomical therapeutic chemical/defined daily dose system, adjusted for bed-occupancy, provides a clear picture of antibiotics consumption frequency and time-trends within hospitals and especially intensive care departments. Material and methods: For this study we used data of a five-year (2010-2014) period, in therapeutic intensive care department of the Emergency Medicine Institute, which show the consumption dynamics of anti-infectives for systemic use of drugs in grams and value indexes. Results: The defined daily doses (DDD) per 1000 occupied-bed days (DDD/OBD) of antibiotics in therapeutic intensive care department decreased from 1524 in 2010 to 1206 DDD/1000 in 2014 or by 20.87%, however, it is by 11.77% higher than medium consumption of 1052.25 DDD/1000 in intensive care units with the same activity in international hospitals. The value of 54948 lei per DDD/1000 OBD in 2010 recorded a decline to 40754 lei or by 25.84% in 2014. The cost of one medium DDD from 36.05 lei in 2010 decreased to 33.77 lei or by 6.33% in 2014. The average antibiotics annual institution consumption constituting 464.1 DDD/1000 in 2014 was higher by 1.06% comparatively with medium consumption of 459.20 DDD/1000 registered in 1706 international hospitals, and by 35.31% in comparison with global consumption of 343 defined daily doses per 1000 patient-days. Conclusions: The decrease of DDD/1000 OBD and their cost took place as a result of efforts for rational use of antibiotics during the evaluated period. Great opportunities were found for improving rational utilization of anti-infectives for systemic use. en_US
dc.language.iso en en_US
dc.publisher Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” en_US
dc.relation.ispartof Curierul Medical
dc.subject antibiotics en_US
dc.subject defined daily dose en_US
dc.subject consumption en_US
dc.subject rational use en_US
dc.subject hospitals en_US
dc.subject.mesh Anti-Bacterial Agents--supply & distribution en_US
dc.subject.mesh Drug Utilization--economics en_US
dc.subject.mesh Emergency Service, Hospital--economics en_US
dc.subject.mesh Emergency Service, Hospital--organization & administration en_US
dc.subject.mesh Hospital Departments--organization & administration en_US
dc.title Evaluation of antibiotics consumption in therapeutic intensive care department en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics